Europe — EMA
Numeta G19e
Valine, the active ingredient in Numeta G19e, is a parenteral nutrition supplement presented as a sterile solution for intravenous use.
Request sourcing
What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
Valine, the active ingredient in Numeta G19e, is a parenteral nutrition supplement presented as a sterile solution for intravenous use. It supports metabolic needs in patients requiring comprehensive amino acid supplementation, particularly in critical care and neonatal settings. GNH USA supplies Numeta G19e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Numeta G19e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio used for?
Numeta G19e is used in clinical nutrition to address amino acid requirements in patients with complex metabolic needs.
- Critical care patients: provides balanced amino acids to support protein synthesis and nitrogen balance. - Neonatal intensive care: supplies essential amino acids for growth and development in preterm infants. - Post‑surgical recovery: aids in tissue repair and immune function through comprehensive amino acid provision. - Chronic kidney disease management: assists in maintaining nutritional status while limiting nitrogen waste. - Severe malnutrition: contributes to re‑establishment of lean body mass during nutritional rehabilitation.
What are the side effects of Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
Numeta G19e may be associated with infusion‑related reactions and metabolic disturbances.
Common Side Effects: - Mild hyperglycaemia: transient rise in blood glucose during infusion. - Electrolyte shifts: minor changes in potassium or phosphate levels. - Local irritation: redness or discomfort at the infusion site. - Nausea: occasional feeling of queasiness during or after infusion. - Headache: mild headache reported by some patients.
Serious or Rare Side Effects: - Severe hypersensitivity: rash, bronchospasm, or anaphylaxis. - Metabolic acidosis: significant drop in blood pH. - Hyperosmolar reactions: fluid overload or pulmonary edema. - Thrombophlebitis: inflammation of the vein with clot formation. - Sepsis: infection related to catheter or infusion equipment.
What precautions apply to Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?
Before initiating Numeta G19e, assess patient-specific factors and monitor relevant parameters.
- Renal impairment: adjust infusion rate and monitor nitrogen waste. - Hepatic dysfunction: observe liver function tests and ammonia levels. - Fluid balance: track input/output to avoid overload. - Electrolyte monitoring: check serum potassium, phosphate, and calcium regularly. - Glycaemic control: monitor blood glucose in diabetic or stress‑hyperglycaemic patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio interact with?
Numeta G19e can interact with other intravenous solutions and medications that affect electrolyte or fluid balance.
Major Interactions (Avoid): - High‑dose potassium chloride: may cause dangerous hyperkalaemia when combined with amino‑acid solutions. - Calcium‑containing solutions: risk of precipitation when mixed directly with amino‑acid admixtures.
Moderate Interactions (Monitor Closely): - Diuretics: may amplify electrolyte shifts, requiring closer monitoring. - Insulin therapy : adjust insulin dosing to account for glucose‑‑ in‑ the infusion of am‑ - - """" " " " " " "" " "" " " "" " " " "" " " " " "" " " " "" " " " "" - " " " - t " "